Georgia Advocacy Office v. Borison

520 S.E.2d 701, 238 Ga. App. 780, 99 Fulton County D. Rep. 2670, 1999 Ga. App. LEXIS 935
CourtCourt of Appeals of Georgia
DecidedJune 30, 1999
DocketA99A0235
StatusPublished
Cited by1 cases

This text of 520 S.E.2d 701 (Georgia Advocacy Office v. Borison) is published on Counsel Stack Legal Research, covering Court of Appeals of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Georgia Advocacy Office v. Borison, 520 S.E.2d 701, 238 Ga. App. 780, 99 Fulton County D. Rep. 2670, 1999 Ga. App. LEXIS 935 (Ga. Ct. App. 1999).

Opinions

Judge Harold R. Banke.

The Georgia Advocacy Office (“GAO”) appeals an order of the superior court denying a request by GAO to inspect and to be provided with certain information concerning the records of patients of Richard Borison, M.D. and Bruce Diamond, M.D. The underlying case arose after these two physicians were indicted for criminal misconduct involving fraudulent drug studies. Following the criminal indictments, the State instituted a civil forfeiture action against the assets of Borison and Diamond.

To comply with certain federal statutes, the Governor designated GAO as this State’s protection and advocacy (“P&A”) system to champion the legal rights of individuals with mental illnesses and developmental and other disabilities.1 42 USC § 10803. See In the Interest of A. V. B., 222 Ga. App. 241, 242 (474 SE2d 114) (1996). Under the Protection & Advocacy Individual Rights Act (“PAIR”), an advocacy system must protect persons with disabilities who fit neither the statutory definition of mentally ill nor developmentally disabled including individuals who are not in residential facilities. 29 USC § 794e (a).

After a series of articles published in the Atlanta newspapers detailed Borison and Diamond’s bogus clinical trials and alleged incidents of abuse and neglect of study participants, GAO launched its own independent investigation. GAO sought to ascertain whether patients who participated in any of the 82 clinical drug trials conducted by Borison and Diamond had actually been subjected to abuse or neglect. GAO also wanted to inform any victims of such miscon[781]*781duct about their legal rights.

After learning that the court-appointed receiver in the State’s civil forfeiture action had custody and control of the medical records of all participants in the 82 drug studies, GAO contacted that receiver. Citing several federal statutes, GAO asserted that it had a legal right to be provided the full names and addresses of all individuals who participated in any of the 82 drug studies which were the subject of the February 18 indictments. GAO also asked the receiver to make the records available for its inspection.2

Notwithstanding the fact that federal law explicitly mandates that all protection and advocacy systems, like GAO, “maintain the confidentiality of patient records to the same extent as is required of the provider” (42 USC § 10806 (a)), the receiver denied GAO’s request, claiming that “all the records of the individuals involved in those studies . . . are confidential and protected from disclosure.” The receiver refused to supply any patient records or names and addresses without releases instructing him to do so.

The receiver filed a Petition for Direction in the Superior Court of Columbia County seeking:

to obtain either the Court’s protection from the requirement to produce the names and the documents listed in the letter of the Georgia Advocacy Office, or in the alternative, the Receiver would request the Court to direct and order the Receiver specifically as to what course of action he is to take.

After a hearing on this petition, the trial court issued an order directing the receiver to deny GAO’s request for information and records. Relying solely on part of one federal statute, PAMII, 42 USC § 10805 (a) (4), the court concluded that GAO failed to demonstrate that it had authority to seek the names, addresses or records of the study participants of the clinical drug trials conducted by Borison and Diamond.

GAO appeals that order, contending that the trial court erred by considering only the most restrictive federal statute and not other applicable federal statutes. It asserts that it has a legal right to the information being sought. Held:

Under the federal statutory framework, to obtain patients’ records, absent an actual client relationship, a P&A system: (1) must [782]*782have “probable cause” as defined by federal law, and (2) must show that the records sought belong to a person fitting within the contours of one of the pertinent federal statutes, PAMII, PADD, and PAIR, and (3) must show the existence of certain specified circumstances under those laws. See 42 USC §§ 6042 (a) (2) (I) (i); 10805 (a) (4) (A).

Under both PAMII and PADD, a P&A system has a right of access to records of individuals only in three delineated circumstances. A system may obtain the records of any individual who is a client of the system where such individual or his legal guardian or representative has authorized the system to have access. 42 USC §§ 6042 (a) (2) (I) (i); 10805 (a) (4) (A). Alternatively, a system may obtain the records of any individual who is unable to authorize the system to have such access, who does not have a legal guardian or representative or whose guardian is the State, and with respect to whom either a complaint has been received or there is probable cause to.believe that such individual has been subjected to or is being subjected to abuse or neglect. 42 USC §§ 6042 (a) (2) (I) (ii); 10805 (a) (4) (B). A system may also obtain access to the records of any individual who has a legal guardian or representative and with respect to whom there is probable cause to believe that such individual has been subject to abuse or neglect, if such representative has been contacted by the system, the system has offered its assistance to resolve the situation, and the representative has failed or refused to act. 42 USC §§ 6042 (a) (2) (I) (iii); 10805 (a) (4) (C).

Congress broadly defined “probable cause” under PAMII to mean: “reasonable grounds for belief that an individual with mental illness has been, or may be at significant risk of being subject to abuse or neglect.” 42 CFR § 51.2. PADD uses a similar definition of probable cause in this context. 45 CFR § 1386.19. Under the statutory framework, the designated P&A system, not a court, makes the determination as to “probable cause.” See Ala. Disabilities Advocacy Program v. J. S. Tarwater Developmental Center, 97 F3d 492, 498-499 (11th Cir. 1996);

By federal law, where media reports, general investigations, inspection reports and other credible information regarding abuse and neglect create probable cause, P&A systems are authorized and expected to conduct investigations.3 See 45 CFR § 1386.22 (a) (iii) (probable cause can be the result of monitoring or other activities including media reports and newspaper articles); Tarwater, 97 F3d at 498-499. Based on the criminal indictments against Borison and Diamond, various media accounts, the guilty plea by one defendant, and [783]*783GAO’s own investigation, GAO plainly had probable cause within the meaning of these federal statutes to investigate further.4

Armed with a showing of “probable cause” as defined by federal law, GAO then contacted the receiver to obtain additional facts. But at that juncture, GAO’s efforts became stymied. Although GAO presented probable cause suggesting that numerous persons may have been victimized, it could not identify them by name.5 Nor could GAO initiate contact with unidentified persons.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
520 S.E.2d 701, 238 Ga. App. 780, 99 Fulton County D. Rep. 2670, 1999 Ga. App. LEXIS 935, Counsel Stack Legal Research, https://law.counselstack.com/opinion/georgia-advocacy-office-v-borison-gactapp-1999.